ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för lenalidomide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

15 träffar

Bibliografisk träff 2012-02-01

p53 nuclear expression correlates with hemizygous TP53 deletion and predicts an adverse outcome for patients with relapsed/refractory multiple myeloma treated with lenalidomide.

Chen MH, Qi CX, Saha MN, Chang H.

Am J Clin Pathol · research support, non-u.s. gov't; journal article · DOI 10.1309/ajcphc85dgaxzdbe

Bibliografisk träff 2012-01-31

Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma.

Touzeau C, Blin N, Clavert A, Roland V, Loirat M, Tessoulin B, Le Gouill S, Planche L, Pennetier M, Mahe B, Mohty M, Malard F, Peterlin P, Dubruille V, Moreau P.

Leuk Lymphoma · journal article · DOI 10.3109/10428194.2011.654116

Bibliografisk träff 2012-01-13

Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function.

Tai YT, Horton HM, Kong SY, Pong E, Chen H, Cemerski S, Bernett MJ, Nguyen DH, Karki S, Chu SY, Lazar GA, Munshi NC, Desjarlais JR, Anderson KC, Muchhal US.

Blood · research-article; journal article · DOI 10.1182/blood-2011-06-364521

Bibliografisk träff 2012-01-12

Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses.

Noonan K, Rudraraju L, Ferguson A, Emerling A, Pasetti MF, Huff CA, Borrello I.

Clin Cancer Res · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1158/1078-0432.ccr-11-1221

Bibliografisk träff 2012-01-11

Lenalidomide alone or lenalidomide plus dexamethasone significantly inhibit IgG and IgM in vitro... A possible explanation for their mechanism of action in treating multiple myeloma.

Shannon E, Sandoval F, Greig N, Stagg P.

Int Immunopharmacol · research support, n.i.h., intramural; research-article; journal article · DOI 10.1016/j.intimp.2011.12.023

Bibliografisk träff 2012-01-01

Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemia.

Carballido E, Veliz M, Komrokji R, Pinilla-Ibarz J.

Cancer Control · review; journal article · DOI 10.1177/107327481201900106

Bibliografisk träff 2012-01-01

Advantageous use of lenalidomide in multiple myeloma: discussion of three case studies.

João C, Figueiredo A, Martins HF.

Curr Opin Oncol · review; journal article; case reports · DOI 10.1097/01.cco.0000410244.91697.5a

Bibliografisk träff 2012-01-01

Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.

Mariz JM, Esteves GV.

Curr Opin Oncol · review; journal article · DOI 10.1097/01.cco.0000410243.84074.dc

Bibliografisk träff 2011-12-06

Safety and efficacy of lenalidomide in relapsed or refractory multiple myeloma.

Alegre A, Vicuña I, Aguado B.

Clin Med Insights Oncol · review-article; journal article · DOI 10.4137/cmo.s7275

Bibliografisk träff 2011-11-23

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.

Khan ML, Reeder CB, Kumar SK, Lacy MQ, Reece DE, Dispenzieri A, Gertz MA, Greipp P, Hayman S, Zeldenhurst S, Dingli D, Lust J, Russell S, Laumann KM, Mikhael JR, Leif Bergsagel P, Fonseca R, Vincent Rajkumar S, Keith Stewart A.

Br J Haematol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1365-2141.2011.08949.x

Bibliografisk träff 2011-11-09

The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes.

Palumbo A, Freeman J, Weiss L, Fenaux P.

Expert Opin Drug Saf · review; journal article · DOI 10.1517/14740338.2011.619975

Bibliografisk träff 2011-10-13

Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

Malard F, Kröger N, Gabriel IH, Hübel K, Apperley JF, Basak GW, Douglas KW, Geraldes C, Jaksic O, Koristek Z, Lanza F, Lemoli R, Mikala G, Selleslag D, Worel N, Mohty M, Duarte RF.

Biol Blood Marrow Transplant · comparative study; clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1016/j.bbmt.2011.10.003

Bibliografisk träff 2011-09-19

Genomic stratification of multiple myeloma treated with novel agents.

Jiang A, Reece D, Chang H.

Leuk Lymphoma · research support, non-u.s. gov't; review; journal article · DOI 10.3109/10428194.2011.608449

Bibliografisk träff 2011-08-11

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.

Larocca A, Cavallo F, Bringhen S, Di Raimondo F, Falanga A, Evangelista A, Cavalli M, Stanevsky A, Corradini P, Pezzatti S, Patriarca F, Cavo M, Peccatori J, Catalano L, Carella AM, Cafro AM, Siniscalchi A, Crippa C, Petrucci MT, Yehuda DB, Beggiato E, Di Toritto TC, Boccadoro M, Nagler A, Palumbo A.

Blood · clinical trial, phase iii; comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1182/blood-2011-03-344333

Bibliografisk träff 2011-04-30

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.

Palladini G, Russo P, Foli A, Milani P, Lavatelli F, Obici L, Nuvolone M, Brugnatelli S, Invernizzi R, Merlini G.

Ann Hematol · research support, non-u.s. gov't; journal article · DOI 10.1007/s00277-011-1244-x